Lei Zhu

5.1k total citations
92 papers, 4.3k citations indexed

About

Lei Zhu is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Lei Zhu has authored 92 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 28 papers in Biomedical Engineering and 20 papers in Oncology. Recurrent topics in Lei Zhu's work include Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (15 papers) and Peptidase Inhibition and Analysis (13 papers). Lei Zhu is often cited by papers focused on Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (15 papers) and Peptidase Inhibition and Analysis (13 papers). Lei Zhu collaborates with scholars based in China, United States and South Korea. Lei Zhu's co-authors include Xiaohong Chen, Fan Zhang, Shi Gao, Ying Ma, Xinglu Huang, Qingjie Ma, Guohao Wang, Seulki Lee, Liwen Zhang and Kai Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Lei Zhu

90 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lei Zhu China	40	2.0k	1.4k	1.1k	933	501	92	4.3k
Fei Yan China	43	3.4k 1.7×	1.5k 1.0×	994 0.9×	1.3k 1.4×	423 0.8×	195	5.5k
Ying Ma United States	45	2.2k 1.1×	2.0k 1.4×	1.0k 0.9×	953 1.0×	1.2k 2.3×	137	5.8k
Qizhen Cao United States	24	1.4k 0.7×	1.2k 0.8×	1.1k 1.0×	720 0.8×	847 1.7×	32	3.6k
Rong Cai China	29	1.7k 0.8×	1.4k 0.9×	1.1k 1.0×	1.2k 1.3×	137 0.3×	118	4.1k
Yu Cheng China	36	1.8k 0.9×	1.3k 0.9×	612 0.5×	1.2k 1.3×	162 0.3×	88	4.1k
Weisheng Guo China	41	3.4k 1.7×	1.7k 1.2×	2.4k 2.1×	1.4k 1.4×	277 0.6×	107	5.9k
Ye Tian China	36	1.6k 0.8×	1.3k 0.9×	1.2k 1.1×	599 0.6×	134 0.3×	123	4.1k
Menachem Motiei Israel	30	1.5k 0.7×	1.0k 0.7×	761 0.7×	965 1.0×	268 0.5×	83	3.2k
Bing He China	43	1.8k 0.9×	2.2k 1.5×	636 0.6×	2.0k 2.2×	199 0.4×	141	5.3k
Xuan Zhang China	44	2.5k 1.2×	2.1k 1.4×	1.0k 0.9×	2.4k 2.5×	185 0.4×	113	5.3k

Countries citing papers authored by Lei Zhu

Since Specialization

Citations

This map shows the geographic impact of Lei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Zhu more than expected).

Fields of papers citing papers by Lei Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Zhu. The network helps show where Lei Zhu may publish in the future.

Co-authorship network of co-authors of Lei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Zhu. A scholar is included among the top collaborators of Lei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Zhu. Lei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Lei, Huimin Wu, Yue Li, et al.. (2024). Casein phosphopeptide interferes the interactions between ferritin and ion irons. Food Chemistry. 454. 139752–139752. 3 indexed citations

Hu, Xiaozhi, Hong Lu, Haile Ma, et al.. (2024). 96P Liposomal irinotecan + 5-FU/LV + bevacizumab for second-line treatment of metastatic colorectal cancer (IRIS): A prospective, multi-center, single-arm clinical study. Annals of Oncology. 35. S1440–S1440. 2 indexed citations

Zhao, Min, Junzhi Liu, Xiaoguang Ge, et al.. (2022). Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer. Biomaterials Advances. 141. 213115–213115. 2 indexed citations

Leo, Angela, Erica Pranzini, Laura Pietrovito, et al.. (2021). Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells. Cancers. 13(14). 3551–3551. 2 indexed citations

Liu, Yang, et al.. (2021). Study on the correlation between the circle of Willis structure and collateral circulation in bilateral carotid artery occlusion. Neurological Sciences. 42(12). 5335–5342. 8 indexed citations

Yu, Mengchao, et al.. (2021). The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer. The International Journal of Biochemistry & Cell Biology. 135. 105982–105982. 12 indexed citations

Cao, Jianbo, Xinglu Huang, Guifeng Fu, et al.. (2016). Monitoring of the tumor response to nano-graphene oxide-mediated photothermal/photodynamic therapy by diffusion-weighted and BOLD MRI. Nanoscale. 8(19). 10152–10159. 53 indexed citations

Chang, Di, Yuancheng Wang, Yingying Bai, et al.. (2015). Role of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe. Scientific Reports. 5(1). 16951–16951. 26 indexed citations

Zhang, Fan, Jianbo Cao, Xiaohong Chen, et al.. (2015). Noninvasive Dynamic Imaging of Tumor Early Response to Nanoparticle-mediated Photothermal Therapy. Theranostics. 5(12). 1444–1455. 31 indexed citations

10.

Niu, Gang, Lei Zhu, Don Ho, et al.. (2013). Longitudinal Bioluminescence Imaging of the Dynamics of Doxorubicin Induced Apoptosis. Theranostics. 3(3). 190–200. 32 indexed citations

11.

Guo, Jinxia, Lixin Lang, Shuo Hu, et al.. (2013). Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers. Molecular Imaging and Biology. 16(2). 274–283. 41 indexed citations

12.

Kiesewetter, Dale O., Ning Guo, Jinxia Guo, et al.. (2012). Evaluation of an [¹⁸F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma. Theranostics. 2(10). 999–1009. 60 indexed citations

13.

Zhang, Fan, Xinglu Huang, Lei Zhu, et al.. (2012). Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles. Biomaterials. 33(21). 5414–5422. 90 indexed citations

14.

Zhang, Fan, Lei Zhu, Xinglu Huang, Gang Niu, & Xiaohong Chen. (2012). Differentiation of Reactive and Tumor Metastatic Lymph Nodes with Diffusion-weighted and SPIO-Enhanced MRI. Molecular Imaging and Biology. 15(1). 40–47. 46 indexed citations

15.

Lang, Lixin, Weihua Li, Ning Guo, et al.. (2011). Comparison Study of [¹⁸F]FAl-NOTA-PRGD2, [¹⁸F]FPPRGD2, and [⁶⁸Ga]Ga-NOTA-PRGD2 for PET Imaging of U87MG Tumors in Mice. Bioconjugate Chemistry. 22(12). 2415–2422. 128 indexed citations

16.

Lang, Lixin, Weihua Li, Hongmei Jia, et al.. (2011). New Methods for Labeling RGD Peptides with Bromine-76. Theranostics. 1. 341–353. 23 indexed citations

17.

Jacobson, Orit, Lei Zhu, Gang Niu, et al.. (2010). MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides. Molecular Imaging and Biology. 13(6). 1224–1233. 48 indexed citations

18.

Ye, Yunpeng, Lei Zhu, Ying Ma, Gang Niu, & Xiaohong Chen. (2010). Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging. Bioorganic & Medicinal Chemistry Letters. 21(4). 1146–1150. 40 indexed citations

19.

Wang, Hongwei, et al.. (2009). [The effects of WT1 gene down regulation on the sensitivity of K562/A02 cells to adriamycin].. PubMed. 30(6). 373–6. 1 indexed citations

20.

Hekim, Can, Jari Leinonen, Ale Närvänen, et al.. (2006). Novel Peptide Inhibitors of Human Kallikrein 2. Journal of Biological Chemistry. 281(18). 12555–12560. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact